Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial-Reference-Cited by-同舟云学术

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

Published:2020-07 Issue:7 Volume:7 Page:e472-e481
ISSN:2352-3018
Container-title:The Lancet HIV
language:en
Short-container-title:The Lancet HIV

Author:

Landovitz Raphael J,Li Sue,Eron Joseph J,Grinsztejn Beatriz,Dawood Halima,Liu Albert Y,Magnus Manya,Hosseinipour Mina C,Panchia Ravindre,Cottle Leslie,Chau Gordon,Richardson Paul,Marzinke Mark A,Eshleman Susan H,Kofron Ryan,Adeyeye Adeola,Burns David,Rinehart Alex R,Margolis David,Cohen Myron S,McCauley Marybeth,Hendrix Craig W

Funder

National Institute of Allergy and Infectious Diseases

Publisher

Elsevier BV

Subject

Virology,Infectious Diseases,Immunology,Epidemiology

Reference23 articles.

1. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

2. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

3. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana;Thigpen;N Engl J Med,2012

4. On-demand preexposure prophylaxis in men at high risk for HIV-1 infection;Molina;N Engl J Med,2015

5. Pre-exposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial;McCormack;Lancet,2016

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV Pre-Exposure Prophylaxis;Infectious Disease Clinics of North America;2024-09

2. PrEP Method Switching: Will it Yield Greater Coverage of HIV Protection? Applying Lessons Learned from Family Planning to Guide Future Research in the Context of PrEP Choice;Current HIV/AIDS Reports;2024-07-24

3. Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-07

4. Adult Human Brain Tissue Cultures to Study NeuroHIV;Cells;2024-06-29

5. Clinical pharmacology considerations and drug–drug interactions with long‐acting cabotegravir and rilpivirine relevant to sub‐Saharan Africa;British Journal of Clinical Pharmacology;2024-06-25